BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 2, 2017
View Archived Issues
Therapix Biosciences begins nonclinical studies of THX-150
Read More
Shire offers overview of pipeline developments in third quarter 2017
Read More
AbbVie reflects on accomplishments of third quarter 2017
Read More
CB-1763 demonstrates excellent antitumor activity in BTK driven-xenograft mouse model
Read More
Impel Neuropharma doses first patient in phase I study of INP-104
Read More
Akcea Therapeutics reports positive data from phase I/IIa study of AKCEA-APOCIII-LRx
Read More
Second-generation PSMA ligands 177Lu-RPS-068 and 177Lu-RPS-063 show increased tumor uptake
Read More
Novel LIF/LIFR inhibitor EC-359 demonstrates therapeutic potential in preclinical cancer models
Read More
European Commission grants orphan drug status to Agilis' AGIL-FA
Read More
Rice University discovers novel viridicatumtoxin B analogues
Read More
New ALK tyrosine kinase receptor inhibitors identified at Blueprint Medicines
Read More
Skyline Antiinfectives patents new deuterated monobactam antibiotics
Read More
Cancer Research Technology presents novel RET kinase inhibitors
Read More
RegeneRx reports results from ARISE-2 study of RGN-259
Read More
Esteve identifies novel dual sigma1 and mu opioid receptor ligands
Read More
FDA gives fast track designation to imetelstat for lower risk MDS
Read More
Incyte and AstraZeneca expand clinical collaboration to study epacadostat and durvalumab in NSCLC
Read More
Calquence approved and available to order in U.S. for mantle cell lymphoma
Read More
EA Pharma signs Korean license agreement with JW Pharmaceutical for AJT-240
Read More
Veloce BioPharma initiates phase II trial of VBP-926 for chemotherapy-associated paronychia
Read More
Sanofi, Regeneron report positive results from phase III study of dupilumab in asthma
Read More
Visterra receives fast track status from FDA for VIS-410
Read More
FDA awards rare pediatric disease designation to ArQule's miransertib
Read More
T-025 demonstrates antitumor activity via the MDM4-p53 pathway
Read More
New phase II trial investigates SPI-1005 for bipolar disorder
Read More
FDA awards breakthrough therapy designation to GSK-2857916 for multiple myeloma
Read More
Sarepta Therapeutics and Duke University enter CRISPR/Cas9 technology license agreement
Read More
Novel ADC for the treatment of colorectal cancers and other GI malignancies
Read More
Symic Bio reports results from SHIELD study of SB-030 in peripheral vascular disease
Read More
FDA committee recommends approval of Braeburn Pharmaceuticals' CAM-2038 for opioid use disorder
Read More